These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7112492)

  • 1. [Ticlopidine: blood and liver involvement?].
    Biour M; Toussaint P; Duhamel G; Canuel C; Krulick M; Calmus Y
    Therapie; 1982; 37(2):222-4. PubMed ID: 7112492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholestatic hepatitis. Presumptive role of ticlopidine].
    Eugene C; Lefebvre JF; Gury B; Quevauvilliers J
    Sem Hop; 1983 Nov; 59(42):2923-4. PubMed ID: 6318329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hematological toxicity of ticlopidine? (author's transl)].
    de Gramont A; Canuel C; Krulik M; Bauters F; Degos L; Marty M; Najean Y
    Nouv Rev Fr Hematol (1978); 1982; 24(1):35-7. PubMed ID: 7071010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of ticlopidine on the natural course of retinal vein occlusion.
    Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
    Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of platelet aggregation in patients treated with ticlopidine].
    Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
    Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients.
    Lecrubier C; Girard P; Noire P; Samama M
    Agents Actions Suppl; 1984; 15():60-7. PubMed ID: 6592946
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-platelet drugs during chronic hemodialysis: an experience with ticlopidine, the 5-(o-chlorobenzyl)-4,5,6,7-tetrahydrothieno-[3,2-c] pyridine.
    Bono F; De Gasperi T; Zanelli P; Menta R; Castiglioni A; Savazzi GM; Cambi V
    Farmaco Prat; 1983 Dec; 38(12):451-5. PubMed ID: 6662220
    [No Abstract]   [Full Text] [Related]  

  • 8. [The antiaggregation effect of ticlopidine on blood platelets preliminary results and prospectives for studies in various diseases].
    Andriani A; Chiappetta MG; Fabiani M; Mosiello G; Beni A
    Clin Ter; 1983 Feb; 104(3):219-22. PubMed ID: 6345050
    [No Abstract]   [Full Text] [Related]  

  • 9. Ticlopidine as a hemorrhagic risk factor in coronary surgery.
    Criado A; Juffé A; Carmona J; Otero C; Avello F
    Drug Intell Clin Pharm; 1985 Sep; 19(9):673-6. PubMed ID: 4042862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of a new platelet aggregation inhibitor, ticlopidine, in hemodialysis].
    Griffanti-Bartoli F; Altomonte F; Pitton L; Armani U; Piana A
    Arch Maragliano Patol Clin; 1979; 35(2):73-80. PubMed ID: 263724
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiaggregant effect of ticlopidine in atherosclerotic patients.
    Manotti C; Potì R; Megna A; Poli T; Alberani M
    Farmaco Prat; 1982 Oct; 37(10):325-30. PubMed ID: 7140941
    [No Abstract]   [Full Text] [Related]  

  • 12. A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study.
    Nyberg G; Larsson O; Westberg NG; Aurell M; Jagenburg R; Blohmé G
    Clin Nephrol; 1984 Mar; 21(3):184-7. PubMed ID: 6705280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of ticlopidine on platelet aggregation: study on 13 atherosclerotic patients].
    Lenci R; Galante A; Borzi M; Ariganello M; Sommariva L; Filice A; Cannata D
    Clin Ter; 1983 Feb; 104(3):205-9. PubMed ID: 6861457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thiophene-induced hepatitis: a new case].
    Hastier P; Bianchi D; Kuhdorf H; Arpurt JP; Chichmanian R; Saint-Paul MC; Delmont J
    Gastroenterol Clin Biol; 1993; 17(8-9):613-4. PubMed ID: 8253330
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in platelet aggregation during treatment with acetylsalicylic acid. Sensitivity of various aggregating agents].
    Lecrubier C; Conard J; Horellou MH; Kher A; Samama M
    Therapie; 1982; 37(5):581-6. PubMed ID: 7179328
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of thrombosis of a blood vessel prosthesis using the anti-aggregation drug ticlid].
    Kirichenko AA; Glukhov AI; Goriunov VS; Smirnova LA
    Kardiologiia; 1985 Aug; 25(8):92-3. PubMed ID: 4068475
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis caused by thiophene].
    Imler M; Chabrier G; Cherfan J; Simon C
    Gastroenterol Clin Biol; 1987 Feb; 11(2):173-4. PubMed ID: 3569740
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new case of hepatitis caused by thiopheol].
    Pouderoux P; Pageaux G; Duhamel O; Gilson J
    Gastroenterol Clin Biol; 1988; 12(8-9):673-4. PubMed ID: 3215433
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis.
    Kohga S; Kinjo M; Tanaka K; Ogawa H; Ishihara M; Tanaka N
    Cancer Res; 1981 Nov; 41(11 Pt 1):4710-4. PubMed ID: 7306988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
    Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.